News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Foster Robert T
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2020 |
4
| Foster Robert T (CEO and Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Bought 25,000 shares
@ $1.5767, valued at
$39.4k
|
|
| 08/21/2020 |
4
| Foster Robert T (CEO,CSO and Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 212,000 options
@ $3.72, valued at
$788.6k
|
|
| 04/07/2020 |
4
| Foster Robert T (CEO and CSO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 380,000 options
@ $1.63, valued at
$619.4k
|
|
| 07/25/2019 |
4
| Foster Robert T (CEO and CSO) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 9,700 options
@ $3.24, valued at
$31.4k
|
|
| 01/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2016 |
3
| Foster Robert T (Chief Scientific Officer) has filed a Form 3 on ContraVir Pharmaceuticals, Inc. |
|
|